North Carolina's #biopharma industry is critical to the state's health and economics. Check out these key state data points:
About us
Since 2007, We Work For Health (WWFH) has been bringing together national and local business leaders, labor, biopharma, patient advocacy and other healthcare-related stakeholders. WWFH is dedicated to promoting policies and initiatives that not only foster innovation and facilitate the delivery of lifesaving or life-enhancing medicines, but also value both the workforce and significant contributions of the biopharmaceutical sector to economies at the national, state and local levels.
- Website
-
weworkforhealth.org
External link for We Work For Health
- Industry
- Biotechnology Research
- Company size
- 1 employee
- Type
- Nonprofit
Employees at We Work For Health
Updates
-
Policymakers and courts have over-thought and over-complicated the U.S. patent system, so the onus is now on Congress to restore common sense #IntellectualProperty reform. Check out this piece in IP Watchdog for more:
Only Congressional Patent Reform Can Restore Constitutional Rights
-
Big Sky Country is big for the life sciences industry, too. Check out our state-by-state breakdown to see Montana's impact in #biopharma workforce and output: https://buff.ly/3OmJLLS
-
-
Did you know ... Mississippi's #biopharma footprint generates more than $3B in economic output? We must continute to encourage innovation for patients, workers and innovators across the state. Read more:
https://www.weworkforhealth.org/_files/ugd/b11210_35c59190842c43118eb1e774915ae0f1.pdf?index=true
weworkforhealth.org
-
With more than 17,000 direct #biopharma jobs and a total of 86,000 jobs, Missouri's economy and patient community benefit from life sciences innovation and output. See more data here: https://buff.ly/4hZlEAM
-
-
Don't miss the latest from the Scientific American about the need for the U.S. to jumpstart research and development on new antimicrobial drugs and shore up the #IntellectualProperty and patent system that propels so many new medicines to market.
The U.S. Must Lead the Global Fight against Superbugs
scientificamerican.com
-
Minnesota's contributions to the U.S #biopharma sphere are nothing short of impactful. See the top data points for public health and local economics here: https://buff.ly/4gfr1dx
-
-
In the Mitten State, innovation is thriving. The #biopharma industry supports more than 100K+ jobs that contribute to advancing life sciences work every day. Learn more: https://buff.ly/3CDwvQA
-
-
The Senate Judiciary Committee recently pass the PREVAIL Act through the committee. We applaud the recognition to address inefficiencies and unfair practices within the Patent Trial and Appeal Board (PTAB). Listen to this clip from Sen. Christopher Coons for more.
-
As this piece in Forbes explains, Congress is considering two crucial bills — the PREVAIL Act and the PERA Act — that would bolster patent protections and lapses in the U.S. #IPRights system. Learn more about the key policy action here:
New Patent Reforms Aim To Fix Unforced Errors
social-www.forbes.com